Heliyon,
Journal Year:
2024,
Volume and Issue:
10(22), P. e40473 - e40473
Published: Nov. 1, 2024
Arsenic
can
cause
extensive
toxic
damage
after
entering
the
body
of
humans
and
animals
by
altering
a
variety
events.
As
most
common
form
methylation
modification
RNA
in
eukaryotic
cells,
N
Biology Direct,
Journal Year:
2023,
Volume and Issue:
18(1)
Published: Sept. 1, 2023
Hepatocellular
carcinoma
(HCC)
is
one
of
the
most
common
and
challenging
cancers
in
world.
N6-methyladenosine
(m6A)
modification
long
non-coding
RNAs
(lncRNAs)
play
critical
roles
progression
HCC.
However,
there
are
few
reports
on
genome-wide
screening
functional
annotations
m6A-methylated
lncRNAs
HCC.The
expression
levels
m6A
methyltransferase
METTL3
association
with
prognosis
HCC
were
determined
by
RT-qPCR,
public
dataset
platforms.
Then,
RNA-seq,
Pearson
correlation
analysis,
MeRIP-qPCR,
RNA
half-life
assay,
gene
site-directed
mutation,
RIP
assay
RT-qPCR
analysis
employed
to
determine
downstream
target
Subsequently,
lncRNA
glucosylceramidase
beta
pseudogene
1
(GBAP1)
Kaplan-meier
curves,
vitro
experiments
vivo
tumorigenesis
lung
metastasis
models.
pathway
GBAP1
explored
GO
biological
process,
KEGG
enrichment,
luciferase
reporter
rescue
so
on.METTL3
was
upregulated
closely
related
prognosis.
And
induced
acting
as
writer
IGF2BP2
worked
its
reader.
Clinically,
significantly
associated
tumor
size,
venous
infiltration,
TNM
stage
HCC,
Functionally,
promoted
growth
both
vivo.
Furthermore,
acted
molecular
sponge
for
miR-22-3p
increase
bone
morphogenetic
protein
receptor
type
1A
(BMPR1A),
which
then
activated
BMP/SMAD
cells.Our
findings
demonstrated
that
METTL3-induced
migration,
invasion
proliferation
cells
via
GBAP1/miR-22-3p/BMPR1A/SMAD
axis.
could
be
a
potential
indicator
therapeutic
Cell Proliferation,
Journal Year:
2023,
Volume and Issue:
57(4)
Published: Nov. 14, 2023
Abstract
Drug
resistance
is
perhaps
the
greatest
obstacle
in
improving
outcomes
for
cancer
patients,
leading
to
recurrence,
progression
and
metastasis
of
various
cancers.
Exploring
underlying
mechanism
worth
further
study.
N6‐methyladenosine
(m6A)
most
common
RNA
modification
found
eukaryotes,
playing
a
vital
role
translation,
transportation,
stability,
degradation,
splicing
processing.
Long
noncoding
(lncRNA)
refers
group
transcripts
that
are
longer
than
200
nucleotides
(nt)
typically
lack
ability
code
proteins.
LncRNA
has
been
identified
play
significant
regulating
multiple
aspects
tumour
development
progression,
including
proliferation,
metastasis,
metabolism,
treatment.
In
recent
years,
growing
body
evidence
emerged,
highlighting
crucial
interplay
between
m6A
lncRNA
determining
sensitivity
cells
chemotherapeutic
agents.
this
review,
we
focus
on
advancements
interaction
modulation
drug
resistance.
Additionally,
aim
explore
mechanisms
involved
process.
The
objective
review
provide
valuable
insights
suggest
potential
future
directions
reversal
chemoresistance
cancer.
The
methylation
of
adenosine
base
at
the
nitrogen-6
position
is
referred
to
as
“N6-methyladenosine
(m
6
A)”
and
one
most
prevalent
epigenetic
modifications
in
eukaryotic
mRNA
noncoding
RNA
(ncRNA).
Various
m
A
complex
components
known
“writers,”
“erasers,”
“readers”
are
involved
function
A.
Numerous
studies
have
demonstrated
that
plays
a
crucial
role
facilitating
communication
between
different
cell
types,
hence
influencing
progression
diverse
physiological
pathological
phenomena.
In
recent
years,
multitude
functions
molecular
pathways
linked
been
identified
osteogenic,
adipogenic,
chondrogenic
differentiation
bone
mesenchymal
stem
cells
(BMSCs).
Nevertheless,
comprehensive
summary
these
findings
has
yet
be
provided.
this
review,
we
primarily
examined
alteration
transcripts
associated
with
transcription
factors
(TFs),
well
other
genes
BMSCs.
Meanwhile,
mutual
interactive
network
modification,
miRNAs,
lncRNAs
was
intensively
elucidated.
last
section,
given
beneficial
effect
modification
osteogenesis
chondrogenesis
BMSCs,
expounded
upon
potential
utility
A-related
therapeutic
interventions
identification
management
human
musculoskeletal
disorders
manifesting
cartilage
destruction,
such
osteoporosis,
osteomyelitis,
osteoarthritis,
defect.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: March 14, 2024
Abstract
As
the
most
prevalent
epitranscriptomic
modification,
N
6
-methyladenosine
(m
A)
shows
important
roles
in
a
variety
of
diseases
through
regulating
processing,
stability
and
translation
target
RNAs.
However,
potential
contributions
m
A
to
RNA
functions
are
unclear.
Here,
we
identified
functional
prognosis-related
A-modified
SREBF2-AS1
hepatocellular
carcinoma
(HCC).
The
expression
SREBF2
HCC
tissues
cells
was
measured
by
RT-qPCR.
modification
level
methylated
immunoprecipitation
assay.
progression
sorafenib
resistance
were
investigated
proliferation,
apoptosis,
migration,
cell
viability
assays.
regulatory
mechanisms
on
Chromatin
isolation
purification,
immunoprecipitation,
CUT&RUN,
bisulfite
DNA
sequencing
Our
findings
showed
that
increased
cells,
positively
correlated
with
poor
survival
patients.
also
prognosis
METTL3
METTL14-induced
upregulated
increasing
transcript
stability.
Functional
assays
only
A-modified,
but
not
non-modified
promoted
resistance.
Mechanistic
investigations
revealed
bound
recruited
reader
FXR1
5-methylcytosine
dioxygenase
TET1
promoter,
leading
demethylation
at
promoter
upregulation
transcription.
rescue
critical
mediator
oncogenic
HCC.
Together,
this
study
exerted
inducing
transcriptional
activation
,
suggested
as
prognostic
biomarker
therapeutic
for
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3078 - 3078
Published: March 27, 2025
Colorectal
cancer
(CRC)
is
a
leading
cause
of
cancer-related
morbidity
and
mortality,
influenced
by
both
genetic
epigenetic
factors.
Long
non-coding
RNAs
(lncRNAs)
such
as
GAS5
CASC8
have
been
implicated
in
susceptibility.
This
study
aimed
to
assess
the
association
rs145204276
ins/del
rs10505477
A>G
polymorphisms
with
CRC
risk
Romanian
population.
A
case-control
was
conducted,
including
156
patients
195
healthy
controls.
Genotyping
for
performed
using
real-time
PCR,
evaluated
logistic
regression
calculate
odds
ratios
(OR)
95%
confidence
intervals
(CI).
The
carriers
del
allele
significantly
associated
increased
(OR:
2.13,
CI:
1.24-3.63,
p
=
0.005)
dominant
model.
In
subgroup
analysis,
polymorphism
restricted
distal
colon
cases
2.98,
1.57-5.66,
0.001),
advanced
tumor
stages
(III
+
IV)
2.54,
1.31-4.91,
0.007),
poorly
differentiated
tumors
(G3)
3.98,
1.49-10.59,
0.009).
No
significant
correlation
found
polymorphism.
may
influence
susceptibility,
particularly
stages.
However,
showed
no
this
cohort.
Modern Rheumatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 16, 2024
The
commonest
type
of
eukaryotic
RNA
modification,
N6-methyladenosine
(m6A),
has
drawn
increased
scrutiny
in
the
context
pathological
functioning
as
well
relevance
determination
stability,
splicing,
transportation,
localization,
and
translation
efficiency.
m6A
modification
plays
an
important
role
several
types
arthritis,
especially
osteoarthritis
rheumatoid
arthritis.
Recent
studies
have
reported
that
regulates
arthritis
pathology
cells,
such
chondrocytes
synoviocytes
via
immune
responses
inflammatory
through
functional
proteins
classified
writers,
erasers,
readers.
aim
this
review
was
to
highlight
recent
advances
relevant
pathogenesis
detail
underlying
molecular
mechanisms,
regulatory
functions,
clinical
applications,
future
perspectives
with
providing
a
foundation
for
research
directions.